n/a (DRTS)

: DRTS · 实时价格 · USD

n/a

n/a (n/a)

收盘价： Invalid Date

暂无数据

买价	n/a
市值	n/a
营收（TTM）	n/a
净利润（TTM）	n/a
贝塔值	n/a
每股收益（TTM）	n/a
市盈率（TTM）	n/a
预期市盈率	n/a
市净率（TTM）	n/a
市销率（TTM）	n/a
Earnings Date	Nov 19, 2026

卖价	n/a
成交量	NaN
20日均量	n/a
开盘价	n/a
前收盘价	n/a
日内区间	n/a - n/a
52周区间	n/a - n/a
分析师	n/a
目标价	n/a
分红	n/a
除息日	n/a

关于 DRTS

A detailed description of the company is not yet available....

[阅读更多]

行业 n/a

板块 n/a

上市日期 n/a

员工人数 n/a

交易所 n/a

股票代码 DRTS

公司完整简介

财报意外

已于 Aug 10, 2026 发布季度财报：

营收为 $0 低于预期 $0, ， NaN% 同比增长.

每股收益为 -0.5 低于预期 -0.36, ， -284.62% 同比下滑.

下次财报发布时间

计划于以下时间发布财报 Nov 19, 2026, 盘中。
分析师预计营收为 ... 升级

新闻

2周前 · Simply Wall St.

Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial

In July 2026, Alpha Tau Medical reported positive podium-presented data from a single-center trial showing that its Alpha DaRT device combined with pembrolizumab achieved a 100% objective response rat...

1月前 · Zacks

New Strong Sell Stocks for July 7th

AMPX, DRTS and BELFB have been added to the Zacks Rank #5 (Strong Sell) List on July 7, 2026.

1月前 · Zacks

New Strong Sell Stocks for July 2nd

DRTS, CANG and LAZ have been added to the Zacks Rank #5 (Strong Sell) List on July 2, 2026.

1月前 · Simply Wall St.

Alpha Tau Medical’s (DRTS) First International Brain Cancer Use Tests The Breadth Of Its Alpha DaRT Platform

Alpha Tau Medical recently reported that its Alpha DaRT technology was used to safely treat a recurrent glioblastoma patient in Israel, marking the first intracranial application of its brain-specific...

2月前 · Stocktwits

DRTS Stock Shot Up A Whopping 22% Today – Why A $196.5M Prostate Cancer Deal Got Investors Buzzing

Alpha Tau signed an agreement with Tolmar to commercialize its lead cancer therapy for prostate cancer in the United States.

第 1 页，共 2 页

n/a (DRTS)

(DRTS) Stock Price, Analysis & Data

关于 DRTS

财报意外

下次财报发布时间

Why Price Moved

新闻

2周前 · Simply Wall St.

1月前 · Zacks

1月前 · Zacks

1月前 · Simply Wall St.

2月前 · Stocktwits